Dry Skin Clinical Trial
Official title:
The Application of Neopep-S Ingredient Easy Dew MD Regen Cream in the Indication of Dry Skin A Prospective Researcher-led Clinical Study to Assess Efficacy and Safety
The purpose of this clinical study is to provide patients diagnosed with dry skin due to various causes such as atopic dermatitis and Yangjin The effect on skin regeneration after applying EasyDew MD Regen Cream containing Neopep-S, a regeneration factor, and It is intended to assess safety.
The total study period for this clinical study is 12 months from the date of IRB approval, led by researchers from a single institution It's a clinical study. The individual participation period of the participant is one month. Subjects are those diagnosed with dry skin due to a variety of factors (and/or courts) Agents) perform screening tests after agreeing in writing to participate in the clinical study. Evaluating the screening test results, and subjects who meet the selection criteria and do not meet the exclusion criteria, for clinical research It must be registered. Random assignments of the study group and control group are conducted in a random number table at a 5:5 ratio. - Control group: 10 people with dexian med cream - Research Group: 10 people applying EasyDew MD Regen Cream Clinical study subjects are randomly assigned to control and study groups. The control group is Dexian, a foreign medical device product Med cream is applied, and in the case of the study group, EasyDewMD Regen cream provided through prescription is applied. clinical practice Subjects apply an appropriate amount twice a day (morning and evening) to skin areas with dry skin symptoms and can be absorbed well Let's make it happen. After applying the medical device for clinical research, the progress is observed for one month, and the subject is subject to about one month of clinical research During the period, research institutes will be regularly visited to evaluate their validity and safety on the day of screening (Visit1), the day of medical device application (Visit2), 2 weeks after medical device application (Visit3), and 1 month after application (Visit4). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05972512 -
A Clinical Study to Assess the Safety and Effectiveness of Plant-based Biotin and Plant Based Biotin With Silica in Healthy Human Subjects With Complaints of Hair Fall, Thin, Dry, & Brittle Hair, and Dry Skin
|
N/A | |
| Completed |
NCT05872113 -
Evaluation of Human Efficacy for Skin Moisturization and Wrinkle Improvement
|
N/A | |
| Completed |
NCT03824886 -
Enhancing SKIN Health and Safety in Aged CARE
|
N/A | |
| Active, not recruiting |
NCT05013645 -
Evaluation of Skin Hydration in Adults With Dry Skin Using a Moisturizer With an Added Sterilized Probiotic
|
N/A | |
| Completed |
NCT04085809 -
This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic
|
N/A | |
| Completed |
NCT05646953 -
Safety and Efficacy Study of Vasu Facial Beauty Oil
|
N/A | |
| Completed |
NCT03804710 -
To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function
|
N/A | |
| Completed |
NCT01305057 -
Efficacy Test on Skin Hydration and Skin Barrier Function
|
N/A | |
| Completed |
NCT05059197 -
Efficacy and Safety of AP Collagen Peptide on the Skin
|
N/A | |
| Completed |
NCT00368563 -
A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin
|
Phase 2/Phase 3 |